Month: November 2022

On November 11, 2021, Mei, Baicheng; Zhou, Yuxing; Schweizer, Kenneth S. published an article.Category: esters-buliding-blocks The title of the article was Long Wavelength Thermal Density Fluctuations in Molecular and Polymer Glass-Forming Liquids: Experimental and Theoretical Analysis under Isobaric Conditions. And the article contained the following:

We establish via an in-depth anal. of exptl. data that the dimensionless compressibility (proportional to the dimensionless amplitude of long wavelength thermal d. fluctuations) of one-component normal and supercooled liquids of chem. complex nonpolar and weakly polar mols. and polymers follows extremely well a surprisingly simple and general temperature dependence over an exceptionally wide range of pressures and temperatures A theor. basis for this behavior is shown to exist in the venerable van der Waals model and its more modern interpretations. Although associated hydrogen bonding (and to a lesser degree strongly polar) liquids display modestly more complex behavior, rather simple temperature and pressure dependences are also discovered. A new approach to collapse the temperature- and pressure-dependent dimensionless compressibility data onto a master curve is formulated that differs from the empirical thermodn. scaling approach. As a practical matter, we also find that the dimensionless compressibility scales well as an inverse power law with temperature with an exponent that is system dependent and decreases with pressure. At very high pressures and low temperatures, the thermal liquid behavior appears to approach (but not reach) a repulsion-dominated random close packing limit. All these findings are relevant to our recent theor. work on the problem of activated relaxation and vitrification of supercooled mol. and polymeric liquids The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).Category: esters-buliding-blocks

The Article related to thermal density fluctuation mol polymer glass liquid isobaric, Physical Properties of Synthetic High Polymers: Physical Properties Of Polymers and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On February 1, 2018, Veluri, Jagan Mohan Reddy; Mustoori, Sairam; Yeruva, Srinivasulu Reddy; Tapas, Barui; Jyothishwaran, Jyothishwaran; Kanduri, Venkata Sada Siva Rao; Furkhan, Tajamul; Malolanarasimhan, Krishnan; Murugan, Ravichandran Narayanasamy; Kedari, Chaitanyakumar; Vasker, Rakesh Goud; Desai, Sahejad published a patent.Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate The title of the patent was Process for preparation, recovery and purification of lirapeptide as a ubiquitin fusion protein and it’s subsequent conversion to liraglutide. And the patent contained the following:

The present application relates to a process for the preparation of peptides or proteins or derivatives thereof by expression of synthetic oligonucleotide encoding desired protein or peptide in prokaryotic cell as ubiquitin fusion construct. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate

The Article related to lirapeptide sequence ubiquitin fusion protein liraglutide conversion, Fermentation and Bioindustrial Chemistry: Pharmaceuticals (Including Nutrients) and other aspects.Name: (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yang, Zeyu; Fu, Hengwei; Ye, Wenjie; Xie, Youyu; Liu, Qinghai; Wang, Hualei; Wei, Dongzhi published an article in 2020, the title of the article was Efficient asymmetric synthesis of chiral alcohols using high 2-propanol tolerance alcohol dehydrogenase SmADH2 via an environmentally friendly TBCR system.Quality Control of (R)-Methyl 3-hydroxybutanoate And the article contains the following content:

Alc. dehydrogenases (ADHs) together with the economical substrate-coupled cofactor regeneration system play a pivotal role in the asym. synthesis of chiral alcs.; however, severe challenges concerning the poor tolerance of enzymes to 2-propanol and the adverse effects of the byproduct, acetone, limit its applications, causing this strategy to lapse. Herein, a novel ADH gene smadh2 was identified from Stenotrophomonas maltophilia by traditional genome mining technol. The gene was cloned into Escherichia coli cells and then expressed to yield SmADH2. SmADH2 has a broad substrate spectrum and exhibits excellent tolerance and superb activity to 2-propanol even at 10.5 M (80%, volume/volume) concentration Moreover, a new thermostatic bubble column reactor (TBCR) system is successfully designed to alleviate the inhibition of the byproduct acetone by gas flow and continuously supplement 2-propanol. The organic waste can be simultaneously recovered for the purpose of green synthesis. In the sustainable system, structurally diverse chiral alcs. are synthesized at a high substrate loading (>150 g L-1) without adding external coenzymes. Among these, about 780 g L-1 (6 M) Et acetoacetate is completely converted into Et (R)-3-hydroxybutyrate in only 2.5 h with 99.9% ee and 7488 g L-1 d-1 space-time yield. Mol. dynamics simulation results shed light on the high catalytic activity toward the substrate. Therefore, the high 2-propanol tolerance SmADH2 with the TBCR system proves to be a potent biocatalytic strategy for the synthesis of chiral alcs. on an industrial scale. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Quality Control of (R)-Methyl 3-hydroxybutanoate

The Article related to asym synthesis chiral alc propanol oxidation alc dehydrogenase, thermostatic bubble column reactor system alc dehydrogenase ketone reduction, Fermentation and Bioindustrial Chemistry: Pharmaceuticals (Including Nutrients) and other aspects.Quality Control of (R)-Methyl 3-hydroxybutanoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 15, 2021, Sasaki, Takashi; Tsuzuki, Yuya; Nakane, Tatsuki published an article.Electric Literature of 118-55-8 The title of the article was A Dynamically Correlated Network Model for the Collective Dynamics in Glass-Forming Molecular Liquids and Polymers. And the article contained the following:

The non-Arrhenius behavior of segmental dynamics in glass-forming liquids is one of the most profound mysteries in soft matter physics. In this article, the authors propose a dynamically correlated network (DCN) model to understand the growing behavior of dynamically correlated regions during cooling, which leads to the viscous slowdown of supercooled liquids The fundamental concept of the model is that the cooperative region of collective motions has a network structure that consists of string-like parts, and networks of various sizes interpenetrate each other. Each segment undergoes dynamical coupling with its neighboring segments via a finite binding energy. Monte Carlo simulations showed that the fractal dimension of the DCNs generated at different temperatures increased and their size distribution became broader with decreasing temperature The segmental relaxation time was evaluated based on a power law with four different exponents for the activation energy of rearrangement with respect to the DCN size. The results of the present DCN model are consistent with the exptl. results for various materials of mol. and polymeric liquids The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).Electric Literature of 118-55-8

The Article related to mol liquid polymer collective dynamics dynamically correlated network model, dynamically correlated network, dynamics, relaxation time, simulation, supercooled liquids, Physical Properties of Synthetic High Polymers: Physical Properties Of Polymers and other aspects.Electric Literature of 118-55-8

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 31, 2013, Camarasa, Marta; Barnils, Christian; Puig de la Bellacasa, Raimon; Teixido, Jordi; Borrell, Jose I. published an article.Category: esters-buliding-blocks The title of the article was A new and practical method for the synthesis of 6-aryl-5,6-dihydropyrido[2,3-d]pyrimidine-4,7(3H,8H)-diones. And the article contained the following:

A one step general synthetic method for the synthesis of 6-aryl-5,6-dihydropyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione derivatives was described. This methodol. is based on treating a 2-aryl-substituted acrylate with a 6-amino-4(3H)-pyrimidinone derivative in the presence of a base under microwave irradiation conditions. The resulting pyrido[2,3-d]pyrimidine derivatives present an aryl substituent at position C6, precisely the one directly related to the biol. activity of such heterocyclic compounds These protocols were extended to other 2-alkyl-substituted and 3-alkyl (or aryl)-substituted acrylate derivatives but with lower yields. The synthesis of the target compounds was achieved by a reaction of 2,6-diamino-4(3H)-pyrimidinone with α-(methylene)benzeneacetic acid Me ester derivatives (acrylate esters), α-methylene-1-naphthaleneacetic acid Me ester, 2-methyl-2-propenoic acid Me ester. 6-Amino-2-(methylthio)-4(3H)-pyrimidinone was also a suitable starting material. The title compounds thus formed included 2-amino-5,8-dihydro-6-(phenyl)pyrido[2,3-d]pyrimidine-4,7(3H,6H)-dione (I) and related substances. The experimental process involved the reaction of Methyl 2-(2,6-difluorophenyl)acetate(cas: 872046-08-7).Category: esters-buliding-blocks

The Article related to pyridopyrimidine preparation, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On August 2, 2019, Gehringer, Matthias; Mader, Patrick; Gersbach, Philipp; Pfeiffer, Bernhard; Scherr, Nicole; Dangy, Jean-Pierre; Pluschke, Gerd; Altmann, Karl-Heinz published an article.Safety of Methyl 2-cyclopentanonecarboxylate The title of the article was Configurationally Stabilized Analogs of M. ulcerans Exotoxins Mycolactones A and B Reveal the Importance of Side Chain Geometry for Mycolactone Virulence. And the article contained the following:

Mycolactones A/B are exotoxins of Mycobacterium ulcerans that are the mol. cause of Buruli ulcer. Mycolactones A/B represent a rapidly equilibrating mixture of Z/E isomers about the C4’=C5′ double bond of the C5-side chain. Here, we describe the syntheses of mycolactone analogs with configurationally stable C5-side chains (E mimetic; Z mimetics). Based on the cytotoxicity of the analogs, the Δ4′,5′-trans isomer of mycolactones A/B appears to be the major virulence factor. The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Safety of Methyl 2-cyclopentanonecarboxylate

The Article related to mycolactone analog preparation cytotoxicity, Biomolecules and Their Synthetic Analogs: Other Bacterial and Fungal Metabolites and other aspects.Safety of Methyl 2-cyclopentanonecarboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On May 15, 2020, Li, Yitao; Lin, Jian; Xu, Junxing; Xiao, Yu; Liu, Xinshuo published a patent.Related Products of 872046-08-7 The title of the patent was Pyrimidinium compound and preparation method and application thereof. And the patent contained the following:

The pyrimidinium compound is represented for example by formula I or a stereoisomer, a nitrogen oxide and a salt thereof of a pyrimidinium compound represented by the formula, a preparation method of the pyrimidinium compound, and an application thereof as an insecticide in agriculture, and a form of an insecticide composition thereof, and a method for controlling pests using the compounds The experimental process involved the reaction of Methyl 2-(2,6-difluorophenyl)acetate(cas: 872046-08-7).Related Products of 872046-08-7

The Article related to pyrimidinium compound preparation insecticide, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Related Products of 872046-08-7

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 26, 2012, Almstetter, Michael; Thormann, Michael; Treml, Andreas; Traube, Nadine published a patent.Product Details of 142327-44-4 The title of the patent was Pyrazolo[4,3-d]pyrimidines useful as kinase inhibitors and their preparation. And the patent contained the following:

The invention relates to pyrazolo[4,3-d]pyrimidine compounds of formula I that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. Compounds of formula I wherein A is NH, O, S, CO, etc.; R1 is alkyl, alkenyl, alkynyl, aryl, etc.; R2 is alkyl, alkenyl, alkynyl, heteroaryl, etc.; R3 is H, halo, NO2, N3, etc.; and pharmaceutically acceptable salts, solvates, hydrates, and pharmaceutically acceptable formulations thereof, are claimed. Example compound II was prepared by amination of 7-chloro-2-(4-methoxybenzyl)-5-phenyl-2H-pyrazolo[4,3-d]pyrimidine with 1H-indazol-5-amine followed by debenzylation. All the invention compounds were evaluated for their kinase inhibitory activity. From the assay, it was determined that compound II exhibited Ki value of less than 10 nM towards SYK, and an IC50 value in the range of 100 nM to 1000 nM towards LRRK2. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Product Details of 142327-44-4

The Article related to pyrazolopyrimidine preparation kinase inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Product Details of 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On February 24, 2022, Su, Wei-Guo; Zhang, Weihan; Deng, Wei; Yang, Haibin published a patent.Formula: C9H8F2O2 The title of the patent was Preparation of pyrimidinone compounds as RIPK1 kinase inhibitors and uses thereof. And the patent contained the following:

The invention relates to pyrimidinone compounds of formula I and their preparation and use RIPK1 kinase inhibitors. Compounds of formula I wherein R1 is H, C1-6 alkyl, C1-6 haloalkyl, etc.; R2 is H, halo, CN, etc.; Z is O, NR3 and CR4R5; R3 is H and C1-6 alkyl; R4 and R5 are each independently H, halo, CN, etc.; ring A is (un)substituted Ph and 5- to 6-membered heteroaryl; ring B is (un)substituted 5- to 12-membered heteroaryl, p is 0 and 1; and their pharmaceutically acceptable salts, solvates, racemic mixtures, enantiomers, diastereomers and tautomers, are claimed. Example compound II was prepared by a multistep procedure (procedure given). The invention compounds were evaluated for their RIPK1 kinase inhibitor activity (data given). The experimental process involved the reaction of Methyl 2-(2,6-difluorophenyl)acetate(cas: 872046-08-7).Formula: C9H8F2O2

The Article related to pyrimidinone preparation ripk1 kinase inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Formula: C9H8F2O2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 11, 2020, Hu, Yonghan; Wu, Dongdong; Peng, Wei; Lu, Liang; Li, Xin; Zhang, Xiuchun; Wang, Ruzhi; Zhu, Sheng; Huang, Bin; Liu, Tao; Zhu, Jinlian; Wu, Yuchuan published a patent.Recommanded Product: 1198284-94-4 The title of the patent was Heterocyclic compound, application and pharmaceutical composition and application. And the patent contained the following:

The invention disclosed a kind of heterocyclic compound, its preparation method and application. The claimed compound is shown in structure I (R1 = H, F, difluoromethyl, OMe, cyclopropyl, etc.; Y1 = N or CH; Y2 = N, CH, C(F), etc.; R9 = H, Me, or difluoromethyl; X1 = N, CH, C(OH), etc.; s,t = 0 or 1; X3 = N; X2 = CH2, or C(O); X4 = hetero atom containing fragment forming heterocycle; X6 = C(O), or CH2. CHR; R = C1-4 alkyl; X5 = N or CH; R6 = H, halo, cyclopropyl, etc.; R7 = H or halo; R8 = (un)substituted C1-4 alkyl, halo, cyclopropyl, oe H). The claimed compound is prepared via multiple steps (procedure given). The prepared compound can be used as RET kinase inhibitor for treating and preventing diseases mediated by abnormal expression of RET such as cancers (papillary thyroid carcinoma, medullary thyroid carcinoma, pheochromocytoma, pancreatic ductal adenocarcinoma, multiple endocrine tumors (also for example MEN2A or MEN2B), breast cancer (also for example metastatic breast cancer), testicular cancer, small cell lung cancer, Non-small cell lung cancer, chronic bone marrow mononuclear leukemia, colon cancer, rectal cancer, ovarian cancer, or salivary adenocarcinoma). The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).Recommanded Product: 1198284-94-4

The Article related to heterocyclic compound preparation ret kinase inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.Recommanded Product: 1198284-94-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics